Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Clinical trial NCT02696993 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02696993
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Malignant Neoplasm in the Brain Stage IV Non-Small Cell Lung Cancer AJCC v7

Start date: 2016-12-16
Primary completion: 2027-12-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.